论文部分内容阅读
透明质酸(Hyaluronic Acid,以下简称HA)是1934年由Meger 和Palmer首次从牛眼玻璃体分离出并命名的。五十多年来,对HA 的分布、理化性质、生理功能及临床应用的研究有了较大的进展。瑞典Pharmacia 药厂于七十年代末推出了一种HA 制剂“Healon”,八十年代初美国也研制出了一种类似制剂“Amvisc”。HA 制剂为无色透明的胶样液体,已被广泛地应用于各种复杂的眼科手术中,如白内障摘出术、人工晶体植入术、抗青光眼手
Hyaluronic Acid (HA) was first isolated and named from bovine vitreous by Meger and Palmer in 1934. Over the past fifty years, great progress has been made in the research on the distribution, physicochemical properties, physiological functions and clinical application of HA. Pharmacia Pharma of Sweden introduced “Healon”, an HA agent, in the late seventies. In the early 1980s, the United States also developed a similar formulation, “Amvisc.” HA preparation for the colorless transparent plastic sample liquid, has been widely used in a variety of complex ophthalmic surgery, such as cataract extraction, intraocular lens implantation, anti-glaucoma hand